(Q48058236)

8 February 2018

title

Pilot randomized trial of selective internal radiation therapy vs. chemoembolization in unresectable hepatocellular carcinoma (English)

1 reference

8 February 2018

adaptive radiation therapy

main subject

0 references

randomized experiment

1 reference

2

1 reference

8 February 2018

Mercedes Iñarrairaegui

4

1 reference

8 February 2018

Alexander R Haug

7

1 reference

8 February 2018

Bruno Sangro

Bruno Sangro

16

0 references

Alberto Benito

Alberto Benito

12

1 reference

ORCID Public Data File 2021

Delia D'Avola

8

Delia D'Avola

1 reference

8 February 2018

Antonio Martínez de la Cuesta

10

Antonio Martinez-Cuesta

1 reference

8 February 2018

Ralf-Thorsten Hoffmann

15

Ralf-Thorsten Hoffmann

1 reference

8 February 2018

author name string

Frank T Kolligs

1

1 reference

8 February 2018

Tobias Jakobs

3

1 reference

8 February 2018

Jutta M Nagel

5

1 reference

8 February 2018

Macarena Rodriguez

6

1 reference

8 February 2018

Mark op den Winkel

9

1 reference

8 February 2018

Christoph Trumm

11

1 reference

8 February 2018

Klaus Tatsch

13

1 reference

8 February 2018

Christoph J Zech

14

1 reference

8 February 2018

publication date

17 January 2015

1 reference

8 February 2018

published in

Liver International

1 reference

8 February 2018

volume

35

1 reference

8 February 2018

issue

6

1 reference

8 February 2018

page(s)

1715-1721

1 reference

8 February 2018

Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial

uses

randomized experiment

0 references

cites work

1 reference

Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma

21 January 2018

1 reference

Survival after yttrium-90 resin microsphere radioembolization of hepatocellular carcinoma across Barcelona clinic liver cancer stages: a European evaluation

21 January 2018

1 reference

Radioembolization results in longer time-to-progression and reduced toxicity compared with chemoembolization in patients with hepatocellular carcinoma

21 January 2018

1 reference

Radioembolization with yttrium-90 glass microspheres in hepatocellular carcinoma: European experience on safety and long-term survival.

21 January 2018

1 reference

Arterial embolization of unresectable hepatocellular carcinoma with use of cyanoacrylate and lipiodol

21 January 2018

1 reference

Quality of life in patients diagnosed with primary hepatocellular carcinoma: hepatic arterial infusion of Cisplatin versus 90-Yttrium microspheres (Therasphere).

21 January 2018

1 reference

Dynamic balanced randomization for clinical trials.

21 January 2018

1 reference

Locoregional radiological treatment for hepatocellular carcinoma; Which, when and how?

21 January 2018

1 reference

Evolving strategies for the management of intermediate-stage hepatocellular carcinoma: available evidence and expert opinion on the use of transarterial chemoembolization.

21 January 2018

1 reference

Radioembolization using 90Y-resin microspheres for patients with advanced hepatocellular carcinoma.

21 January 2018

1 reference

Prospective evaluation of patients with early-/intermediate-stage hepatocellular carcinoma with disease progression following arterial locoregional therapy: candidacy for systemic treatment or clinical trials.

21 January 2018

1 reference

Radioembolization for hepatocellular carcinoma using Yttrium-90 microspheres: a comprehensive report of long-term outcomes

21 January 2018

1 reference

Quality of life and its associated factors in patients with hepatocellular carcinoma receiving one course of transarterial chemoembolization treatment: a longitudinal study.

21 January 2018

1 reference

Quality of life and survival analysis of patients undergoing transarterial chemoembolization for primary hepatic malignancies: a prospective cohort study

21 January 2018

1 reference

Increased Quality of Life Among Hepatocellular Carcinoma Patients Treated With Radioembolization, Compared With Chemoembolization

21 January 2018

1 reference

Longitudinal quality of life assessment of patients with hepatocellular carcinoma after primary transarterial chemoembolization

21 January 2018

1 reference

Response assessment methodologies in hepatocellular carcinoma: complexities in the era of local and systemic treatments

21 January 2018

1 reference

Arterial chemoembolization/embolization and early complications after hepatocellular carcinoma treatment: a safe standardized protocol in selected patients with Child class A and B cirrhosis.

21 January 2018

1 reference

Prognostic factors and prevention of radioembolization-induced liver disease

21 January 2018

1 reference

Comparison of yttrium-90 radioembolization and transcatheter arterial chemoembolization for the treatment of unresectable hepatocellular carcinoma

21 January 2018

1 reference

Response to radioembolization with yttrium-90 resin microspheres may allow surgical treatment with curative intent and prolonged survival in previously unresectable hepatocellular carcinoma

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/LIV.12750

1 reference

8 February 2018

1 reference

8 February 2018